CANADIAN CANNABIS PRICES
Canadian wholesale prices of cannabis will be down by 40% or more in 2022
Canadian cannabis wholesale costs tumbled greater than 40% final yr as firms continued to work by cussed provide gluts and struggling cultivators selected to unload their unsold cannabis as an alternative of destroying it, reviews MJ Biz Every day.
According to this publication, while some business experts see wholesale cannabis prices continuing to fall, others are more bearish.
Steve Clark, the Canadian Cannabis Alternate’s (CX) CEO has mentioned that THC stays the principle barometer for worth, however terpene profiles have gotten extra wanted by consumers, whereas Dan Sutton, CEO of British Columbia-headquartered cannabis producer Tantalus Labs, expects costs will proceed to fall.
CALIFORNIA GRANT PROGRAM
California announces a $20 million grant program for the expansion of cannabis retail licenses in underserved regions
Marijuana Second reviews that California is launching a first-of-its-kind grant program to help cities and counties in establishing native cannabis enterprise licensing applications.
This system aims to satisfy unmet consumer demand and curb the illicit market.
According to the publication’s findings, local governments may be eligible for a reduced amount of $20 million, if they do not have retail licensing programs but intend to create and implement one. So far, 18 counties have been identified as eligible.
In a press release, DCC Director Nicole Elliott stated: “Increasing access to California’s Retail Cannabis Market is a vital step in the direction towards defending shopper safety and supporting a balance market.”
The retail entry grant program aims to encourage the authorized retail operation of cannabis in areas where customers don’t have easy access to it.
JAZZ PHARMACEUTICALS
Has GW Prescription drugs – now Jazz Prescription drugs – knee-capped the CBD business?
As GW Prescription drugs (which was purchased by Irish agency Jazz Prescription drugs for $7.2bn in 2021) has spent hundreds of thousands of {dollars} on lobbying actions, a collection of occasions have unfurled which may finally see it come to dominate the CBD sector, reviews BusinessCann.
The publication highlights that, whereas the European Union indicated Novel Meals could be the pathway for shopper CBD since 2015 – this transfer did play into GW’s fingers.
BusinessCann examines GW’s position in the CBD industry, its lobbying activities, GW’s patents, and the impact of its presence, amongst other things, in France and Brazil.
The following questions are posed to GW:
1. What is the Epidiolex CBD knowledge of the shopper?
2. Will Jazz provide any additional knowledge on Epidiolex to regulators?
3. Some claim that the information provided to the UK Committee on Toxicity revealed security issues, without indicating if the problems were explained or repeated later?
4. How much money has Jazz spent in the UK and US on lobbying?
5. Is CBD best used as a food or medication?